Transforming Process Development with AI: Success Stories from mAbs to Emerging Modalities

Published on: 


Webinar Date/Time: Thu, Thu, Apr 18, 2024 11:00 AM EDT

AI technology is transforming bioprocessing, setting new standards for process performance while reducing development efforts. Join this webinar to understand the impact of this technology across established and emerging modalities.

Register Free:

Event Overview:

Join Dr. Michael Sokolov, COO of DataHow, as he explains the tranformative impact that AI technologies, particularly hybrid modeling and transfer learning, are having on bioprocess development and manufacturing. Armed with richer and more accurate AI-enabled insights, process scientists are able to develop more productive processes (higher yeilds for manufacturing) while reducing development efforts (reduced time and resources in development).

DataHow has been at the forefront of implementing this hybrid modeling- and transfer learning-enabled process development approach, and has worked with the majority of the largest 20 big pharma players. Understand how this AI-enabled development approach will make traditional statistical methods obsolete, and understand how to implement advanced AI solutions in your organization.

Key Learning Objectives:

  • Learn about hybrid modeling and transfer learning compared to standard DOE tools.
  • Understand the impact of these technologies on process development and manufacturing.
  • Understand the potential of this technology through industry case studies.
  • Recognize the huge potential in new modalities alongside established mAb processes.

Who Should Attend:

  • Head of Process Development
  • Head of MSAT
  • Head of Digital / Innovation
  • Process Scientist
  • Data Scientist


Dr. Michael Sokolov
Co-Founder and COO

Dr. Michael Sokolov is Co-Founder and COO of DataHow AG, a spin-off company from ETH Zurich that specializes in process data analytics and modeling, with a particular focus on the biopharmaceutical and chemical domains. Within DataHow, he is managing process modeling and software applications activities with global pharma accounts and coordinating all operational and financial activities of the company. He is also regularly involved in educational courses for university students and industry professionals.

Register Free: